Impact of COVID-19 Disease in Early Breast Cancer Management: A Summary of the Current Evidence

Imagem de Miniatura
Arquivos
art_CAVALCANTE_Impact_of_COVID19_Disease_in_Early_Breast_Cancer_2022.PDF (220 KB)
Citações na Scopus
1
Tipo de produção
article
Data de publicação
2022
DOI
Scopus
Web of Science
PubMed
Título da Revista
ISSN da Revista
Título do Volume
Editora
LIPPINCOTT WILLIAMS & WILKINS
Autores
CAVALCANTE, Francisco Pimentel
FERREIRA, Carlos Eduardo dos Santos
AMORIM, Gilberto
OLIVEIRA, Vilmar Marques de
GUILGEN, Gisah
LANDEIRO, Luciana
JR, Alvaro Pulchinelli
Citação
JCO GLOBAL ONCOLOGY, v.8, article ID e2100357, 11p, 2022
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
The authors discuss the best practices on early breast cancer management during the COVID pandemic. PURPOSE An expert panel on breast cancer and COVID-19 disease was convened to address the impact of the COVID-19 pandemic for early breast cancer (eBC) management. METHODS To ensure that the most clinically relevant information was addressed, essential information was drawn from several of the latest national and international guidelines and another technical document. The expert panel met in five virtual closed sessions from November 2020 to May 2021 to consult on the relevant data from evidence-based results. The data gathered were discussed on an online platform. RESULTS This article reports the expert panel's highlights of these meetings' discussions. In addition, it provides practical recommendations covering topics regarding diagnosis, treatment, and management of patients with eBC in clinical settings routinely encountered by health care professionals amid the COVID-19 pandemic. CONCLUSION This article provided guidance on several topics regarding eBC management amid the COVID-19 pandemics to inform safer care practices.
Palavras-chave
URI
https://observatorio.fm.usp.br/handle/OPI/48432
Referências
  1. Aguiar S, 2020, J SURG ONCOL, V122, P1293, DOI 10.1002/jso.26146
  2. Almahariq MF, 2021, ANN SURG ONCOL, V28, P930, DOI 10.1245/s10434-020-08928-2
  3. American College of Surgeons, COVID 19 GUID TRIAG
  4. Angarita FA, 2018, BREAST CANCER RES TR, V170, P373, DOI 10.1007/s10549-018-4747-5
  5. [Anonymous], 2020, WHO INT GUID, V11, P1
  6. [Anonymous], 2021, COMP AXILLARY LYMPH
  7. [Anonymous], 2021, LOC REACT SYST REACT LOC REACT SYST REACT
  8. [Anonymous], Nota tecnica-Informacoes atualizadas sobre vacinacao contra COVID-19 e Mamografia
  9. Barron AU, 2018, JAMA SURG, V153, P1120, DOI 10.1001/jamasurg.2018.2696
  10. Bartlett DL, 2020, ANN SURG ONCOL, V27, P1717, DOI 10.1245/s10434-020-08461-2
  11. Bi Z, 2019, BREAST CANCER-TOKYO, V26, P373, DOI 10.1007/s12282-018-00934-3
  12. Bitterman R, 2018, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008983.pub3
  13. Boughey JC, 2013, JAMA-J AM MED ASSOC, V310, P1455, DOI 10.1001/jama.2013.278932
  14. Brunt AM, 2018, INT J RADIAT ONCOL, V102, P1603, DOI 10.1016/j.ijrobp.2018.08.049
  15. Brunt AM, 2016, RADIOTHER ONCOL, V120, P114, DOI 10.1016/j.radonc.2016.02.027
  16. Brydak LB, 2001, SUPPORT CARE CANCER, V9, P65, DOI 10.1007/s005200000186
  17. Cai GY, 2021, ONCOIMMUNOLOGY, V10, DOI 10.1080/2162402X.2020.1854424
  18. Cardoso F, 2019, ANN ONCOL, V30, P1194, DOI 10.1093/annonc/mdz173
  19. Caudle AS, 2016, J CLIN ONCOL, V34, P1072, DOI 10.1200/JCO.2015.64.0094
  20. Cavalcante Francisco Pimentel, 2021, J Plast Reconstr Aesthet Surg, V74, P644, DOI 10.1016/j.bjps.2020.08.103
  21. Cavalcante FP, 2020, BREAST CANCER RES TR, V184, P637, DOI 10.1007/s10549-020-05877-y
  22. Centers for Disease Control and Prevention, 2020, US ANT TESTS COVID 1
  23. Centers for Disease Control and Prevention, CLIN QUEST COVID 19
  24. Centers for Disease Control and Prevention, INT US GUID RISK ASS
  25. Centers for Disease Control and Prevention, UPD HEALTHC INF PREV
  26. Centers for Disease Control and Prevention, INT GUID COVID 19 AN
  27. Centers for Disease Control and Prevention, INT CLIN CONS US COV
  28. Centers for Disease Control and Prevention, SEQ PUTT PERS PROT E
  29. Centers for Disease Control and Prevention, LOC REACT SYST REACT
  30. Cheng MP, 2020, ANN INTERN MED, V173, P450, DOI 10.7326/M20-2854
  31. Coates AS, 2015, ANN ONCOL, V26, P1533, DOI 10.1093/annonc/mdv221
  32. Corti C, 2021, EUR J CANCER, V148, P316, DOI 10.1016/j.ejca.2021.01.046
  33. Curigliano G, 2020, BREAST, V52, P8, DOI 10.1016/j.breast.2020.04.006
  34. Czajka ML., 2020, STATPEARLS
  35. Desai A, 2021, NAT REV CLIN ONCOL, V18, P313, DOI 10.1038/s41571-021-00487-z
  36. Dietz JR, 2020, BREAST CANCER RES TR, V181, P487, DOI 10.1007/s10549-020-05644-z
  37. Dinnes J, 2020, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD013705, 10.1002/14651858.CD013705.pub2]
  38. Edmonds CE, 2021, AM J ROENTGENOL, V217, P831, DOI 10.2214/AJR.21.25604
  39. European Society for Medical Oncology, ESMO STAT VACC COVID
  40. European Society for Medical Oncology, ESMO MAN TREATM AD R
  41. Ferreira CE, 2021, INT J INFECT DIS, V103, P260, DOI 10.1016/j.ijid.2020.11.173
  42. Finley C, 2020, CAN J SURG, V63, pS2, DOI [10.1503/cjs.005620, 10.1503/cjs.00562]
  43. Fregatti P, 2020, IN VIVO, V34, P1667, DOI 10.21873/invivo.11959
  44. Giuliano AE, 2017, JAMA-J AM MED ASSOC, V318, P918, DOI 10.1001/jama.2017.11470
  45. Goshen-Lago T, 2021, JAMA ONCOL, V7, P1507, DOI 10.1001/jamaoncol.2021.2675
  46. Grimm L, SBI RECOMMENDATIONS
  47. Hammond MEH, 2010, J CLIN ONCOL, V28, P2784, DOI 10.1200/JCO.2009.25.6529
  48. Han HJ, 2021, INT IMMUNOPHARMACOL, V90, DOI 10.1016/j.intimp.2020.107247
  49. Haviland JS, 2013, LANCET ONCOL, V14, P1086, DOI 10.1016/S1470-2045(13)70386-3
  50. Hoffmann M, 2020, CELL, V181, P271, DOI 10.1016/j.cell.2020.02.052
  51. Hwang ES, 2020, ANN SURG ONCOL, V27, P2600, DOI 10.1245/s10434-020-08673-6
  52. Jatoi A, 2010, LUNG CANCER, V68, P234, DOI 10.1016/j.lungcan.2009.06.020
  53. Kantor O, 2021, ANN SURG ONCOL, V28, P1358, DOI 10.1245/s10434-020-09073-6
  54. Kantor O, 2017, BREAST J, V23, P554, DOI 10.1111/tbj.12793
  55. Kaufman HW, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.17267
  56. Kayani B, 2020, BONE JOINT J, V102B, P1136, DOI 10.1302/0301-620X.102B9.BJJ-2020-1127.R1
  57. Ko G, 2021, BREAST CANCER RES TR, V188, P825, DOI 10.1007/s10549-021-06293-6
  58. Kunkler IH, 2015, LANCET ONCOL, V16, P266, DOI 10.1016/S1470-2045(14)71221-5
  59. Li YF, 2020, J MED VIROL, V92, P903, DOI 10.1002/jmv.25786
  60. Loulergue P, 2011, BRIT J CANCER, V104, P1670, DOI 10.1038/bjc.2011.142
  61. Marcus A, 2014, ADV IMMUNOL, V122, P91, DOI 10.1016/B978-0-12-800267-4.00003-1
  62. Marra A, 2020, ANN ONCOL, V31, pS1206, DOI 10.1016/j.annonc.2020.08.2318
  63. Masuda N, 2017, NEW ENGL J MED, V376, P2147, DOI 10.1056/NEJMoa1612645
  64. Mattioli IA, 2020, ACS SENSORS, V5, P3655, DOI 10.1021/acssensors.0c01382
  65. Mills GH, 2018, ANAESTHESIA, V73, P25, DOI 10.1111/anae.14137
  66. Ministerio da Saude (Brasil), PLAN NAC OP VAC COV
  67. Ministerio da Saude Brasil, 2022, COR BRAS
  68. Miraglia JL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027214
  69. Monin L, 2021, LANCET ONCOL, V22, P765, DOI 10.1016/S1470-2045(21)00213-8
  70. Moo TA, 2021, ANN SURG ONCOL, V28, P6044, DOI 10.1245/s10434-021-09910-2
  71. Moo TA, 2018, ANN SURG ONCOL, V25, P1488, DOI 10.1245/s10434-018-6429-2
  72. National Comprehensive Cancer Network, REC NCCN COVID 19 VA
  73. National Comprehensive Cancer Network, NCCN GUID BREAST CAN
  74. National Institute for Health and Care Excellence, COVID 19 RAP GUID AR
  75. Nepogodiev D, 2021, ANAESTHESIA, V76, P748, DOI 10.1111/anae.15458
  76. O'Connell RL, 2018, BRIT J SURG, V105, P1778, DOI 10.1002/bjs.10959
  77. Ozutemiz C, 2021, RADIOLOGY, V300, pE296, DOI 10.1148/radiol.2021210275
  78. Papautsky EL, 2020, BREAST CANCER RES TR, V184, P249, DOI 10.1007/s10549-020-05828-7
  79. Pray IW, 2021, MMWR-MORBID MORTAL W, V69, P1642, DOI 10.15585/mmwr.mm695152a3
  80. Pryor A., 2020, SAGES EAES RECOMMEND
  81. Ribeiro R, 2021, ANN SURG ONCOL, V28, P1289, DOI 10.1245/s10434-020-09098-x
  82. Robinson KA, 2021, JAMA ONCOL, V7, P1395, DOI 10.1001/jamaoncol.2021.3127
  83. Seely JM, 2021, CAN ASSOC RADIOL J, V72, P601, DOI 10.1177/0846537121998949
  84. Sethuraman N, 2020, JAMA-J AM MED ASSOC, V323, P2249, DOI 10.1001/jama.2020.8259
  85. Sheng JY, 2020, JCO ONCOL PRACT, V16, P665, DOI 10.1200/OP.20.00364
  86. Siegel RL, 2019, CA-CANCER J CLIN, V69, P7, DOI [10.3322/caac.21551, 10.3322/caac.21654]
  87. Simon SD, 2019, BREAST, V44, P113, DOI 10.1016/j.breast.2019.01.008
  88. Spolverato G, 2020, SURGERY, V168, P4, DOI 10.1016/j.surg.2020.04.036
  89. Sung H, 2021, CA-CANCER J CLIN, V71, P209, DOI 10.3322/caac.21660
  90. Tee SR, 2018, BRIT J SURG, V105, P1541, DOI 10.1002/bjs.10986
  91. Thakkar A, 2021, NAT CANCER, V2, P392, DOI 10.1038/s43018-021-00191-y
  92. Thevarajan I, 2020, NAT MED, V26, P453, DOI 10.1038/s41591-020-0819-2
  93. Tutt ANJ, 2021, NEW ENGL J MED, V384, P2394, DOI 10.1056/NEJMoa2105215
  94. Tuttle TM, 2015, ANN SURG ONCOL, V22, P3407, DOI 10.1245/s10434-015-4629-6
  95. Valero MG, 2020, ANN SURG ONCOL, V27, P344, DOI 10.1245/s10434-019-07948-x
  96. von Minckwitz G, 2019, NEW ENGL J MED, V380, P617, DOI 10.1056/NEJMoa1814017
  97. Ward EM, 2017, CA-CANCER J CLIN, V67, P399, DOI 10.3322/caac.21407
  98. World Health Organization, 2020, CELL

Coleções
Artigos e Materiais de Revistas Científicas - FM/MIP
Artigos e Materiais de Revistas Científicas - COVID-19
Artigos e Materiais de Revistas Científicas - HC/ICHC
Artigos e Materiais de Revistas Científicas - IMT
Artigos e Materiais de Revistas Científicas - LIM/07
Artigos e Materiais de Revistas Científicas - LIM/47
Carregar mais